EP2015803A4 - STRUCTURES OF NANOFIBRES PRESENTED ON ASPEERIES INTENDED TO SEQUESTER, WEAR AND TRANSFER SUBSTANCES - Google Patents

STRUCTURES OF NANOFIBRES PRESENTED ON ASPEERIES INTENDED TO SEQUESTER, WEAR AND TRANSFER SUBSTANCES

Info

Publication number
EP2015803A4
EP2015803A4 EP07835752A EP07835752A EP2015803A4 EP 2015803 A4 EP2015803 A4 EP 2015803A4 EP 07835752 A EP07835752 A EP 07835752A EP 07835752 A EP07835752 A EP 07835752A EP 2015803 A4 EP2015803 A4 EP 2015803A4
Authority
EP
European Patent Office
Prior art keywords
aspeeries
nanofibres
sequester
wear
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07835752A
Other languages
German (de)
French (fr)
Other versions
EP2015803A2 (en
Inventor
Darrell H Reneker
Daniel J Smith
David Barrett Meyers
Nevenka Golubovic-Liakopoulos
Alexander Marin
Alexander K Andrianov
Peter G Carroll
Sanford R Simon
Tao Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Apogee Technology Inc
Original Assignee
University of Akron
Apogee Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Akron, Apogee Technology Inc filed Critical University of Akron
Publication of EP2015803A2 publication Critical patent/EP2015803A2/en
Publication of EP2015803A4 publication Critical patent/EP2015803A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/07Bacillus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
EP07835752A 2006-05-09 2007-05-09 STRUCTURES OF NANOFIBRES PRESENTED ON ASPEERIES INTENDED TO SEQUESTER, WEAR AND TRANSFER SUBSTANCES Withdrawn EP2015803A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79892806P 2006-05-09 2006-05-09
US84850506P 2006-09-29 2006-09-29
US84850706P 2006-09-29 2006-09-29
US84821306P 2006-09-29 2006-09-29
US84850406P 2006-09-29 2006-09-29
US84850606P 2006-09-29 2006-09-29
PCT/US2007/011228 WO2008024141A2 (en) 2006-05-09 2007-05-09 Nanofiber structures on asperities for sequestering, carrying and transferring substances

Publications (2)

Publication Number Publication Date
EP2015803A2 EP2015803A2 (en) 2009-01-21
EP2015803A4 true EP2015803A4 (en) 2009-05-06

Family

ID=39107260

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07835752A Withdrawn EP2015803A4 (en) 2006-05-09 2007-05-09 STRUCTURES OF NANOFIBRES PRESENTED ON ASPEERIES INTENDED TO SEQUESTER, WEAR AND TRANSFER SUBSTANCES

Country Status (4)

Country Link
EP (1) EP2015803A4 (en)
AU (1) AU2007288442A1 (en)
CA (1) CA2650197A1 (en)
WO (1) WO2008024141A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
EP2146689B1 (en) 2007-04-16 2020-08-12 Corium, Inc. Solvent-cast microneedle arrays containing active
US20110213335A1 (en) * 2008-11-18 2011-09-01 Burton Scott A Hollow microneedle array and method
AU2015271878B2 (en) * 2010-04-28 2017-05-11 Sorrento Therapeutics, Inc. Device for delivery of rheumatoid arthritis medication
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
RU2585159C2 (en) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Device for delivering drug used in rheumatoid arthritis
MX346337B (en) 2010-04-28 2017-03-14 Kimberly Clark Co Nanopatterned medical device with enhanced cellular interaction.
CN102985131B (en) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 For delivering the medical treatment device of siRNA
WO2011140274A2 (en) 2010-05-04 2011-11-10 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2012130193A1 (en) * 2011-03-31 2012-10-04 Zentiva, K.S. Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
KR20220051429A (en) 2011-10-27 2022-04-26 소렌토 쎄라퓨틱스, 인코포레이티드 Transdermal delivery of high viscosity bioactive agents
ES2908653T3 (en) 2011-10-27 2022-05-03 Sorrento Therapeutics Inc Implantable devices for the administration of bioactive agents
WO2013086731A1 (en) * 2011-12-16 2013-06-20 London Metropolitan University (Lmu) Delivery apparatus
BR102012031954A2 (en) * 2012-12-14 2015-01-20 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt ACTIVE SUBSTANCE NANOFIBERS FOR COSMETIC APPLICATION OF CONTROLLED RELEASE OBTAINED BY ELECTROPHIATION AND PROCESS
BR102012031955A2 (en) * 2012-12-14 2014-10-07 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt NANOFIBRAS CONTAINING ACTIVE SUBSTANCE WITH CONTROLLED RELEASE FOR DONTOLOGICAL APPLICATION AND PROCESS
KR102265808B1 (en) 2012-12-21 2021-06-16 코리움, 인크. Microarray for delivery of therapeutic agent and methods of use
CA2903748C (en) 2013-03-12 2021-11-02 Corium International, Inc. Microprojection applicators
WO2014151654A1 (en) 2013-03-15 2014-09-25 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
AU2014237357B2 (en) 2013-03-15 2019-11-28 Corium Pharma Solutions, Inc. Multiple impact microprojection applicators and methods of use
CA2903763C (en) 2013-03-15 2021-11-16 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
EP2968119B1 (en) 2013-03-15 2019-09-18 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
KR101527469B1 (en) * 2013-11-04 2015-06-11 연세대학교 산학협력단 A Method for Fabrication of Porous fiber microstructure with various 3-dimensional Structures
EP3188714A1 (en) 2014-09-04 2017-07-12 Corium International, Inc. Microstructure array, methods of making, and methods of use
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11040103B2 (en) * 2016-04-15 2021-06-22 Admbioscience Inc. Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film
KR102592782B1 (en) 2017-01-23 2023-10-20 에이에프와이엑스 테라퓨틱스 에스에이 Method for manufacturing two-layer products based on electrospun fibers
DE102017112573A1 (en) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Microneedle system for the application of glucagon-like peptide analogues
EP4041190A1 (en) * 2019-10-08 2022-08-17 Afyx Therapeutics A/S Compositions for the delivery of proteins
WO2021157688A1 (en) * 2020-02-07 2021-08-12 花王株式会社 Skin composition for external use
WO2025024593A2 (en) * 2023-07-25 2025-01-30 The Board Of Trustees Of The Leland Stanford Junior University Apparatuses and methods involving high density bioelectronic fibers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
WO2006027780A2 (en) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
WO2006027780A2 (en) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Also Published As

Publication number Publication date
WO2008024141A8 (en) 2009-07-09
CA2650197A1 (en) 2008-02-28
WO2008024141A2 (en) 2008-02-28
WO2008024141A3 (en) 2008-04-24
AU2007288442A1 (en) 2008-02-28
EP2015803A2 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
EP2015803A4 (en) STRUCTURES OF NANOFIBRES PRESENTED ON ASPEERIES INTENDED TO SEQUESTER, WEAR AND TRANSFER SUBSTANCES
EP1999317A4 (en) WEAR SET
BRPI0815277A2 (en) "PARTICULATE MONITORS"
EP1999654A4 (en) PROPAGATION OF THE RELEVANCE OF DOCUMENTS LABELED TO NON-LABELED DOCUMENTS
BRPI0714539A2 (en) "PHARMACEUTICAL FORMS"
EP2366785A4 (en) OLIGONUCLEOTIDE DERIVATIVE, MARKING AGENT AND USE OF THE MARKING AGENT
BRPI0809787A2 (en) "MAINTENANCE-FREE RESPIRATOR"
DK2010159T3 (en) Quick-release paracetamol tablets
EP2340494A4 (en) CLICK SHARING SNAPSHOTS AND ASSOCIATED DOCUMENTS
BRPI0815430A2 (en) "BREASTFEEDING QUANTIFICATION"
DK2077729T3 (en) ORAL PROBIOTIC DOSAGE FORMS
BRPI0720333A2 (en) "PIPE CONNECTION, THREADED PIPE CONNECTION AND PRINT BEARING"
EP2248091A4 (en) TARGETED ADVERTISEMENTS ON COMMUNITIES
DE602007007073D1 (en) WHEEL AND BRAKE ARRANGEMENTS
EP2297585A4 (en) DETECTION OF THE USE OF CANNABIS
FR2898636B1 (en) STRUCTURE OF TAIL-OF BROWN RADIUS.
DE602006018399D1 (en) Tapered roller bearings
EP2142216A4 (en) PARTICULATE FORMULATIONS AND USES THEREOF
EP2139677A4 (en) IMPROVEMENTS RELATING TO NANOCOMPOSITE AND THE SURFACES THEREOF
EP1991691A4 (en) DETECTION OF THE PATHOGENICITY FACTORS OF ANTHRAX
PL2839836T3 (en) Probiotics for use in reducing the symptoms of respiratory disease
EP2323840A4 (en) IMPROVEMENTS IN CORRUGATED ROLLS
DE502008001462D1 (en) Tapered roller bearings
DE502007006015D1 (en) roller bearing
BRPI0921302A2 (en) clinker, processes for making a clinker and reducing the ability of a clinker to produce dust, produce and use a product.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20090408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090708